Vimarsana
Biggest News Aggregation in the World

Page 18 - Emergent Biosolution News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Emergent Biosolution. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Emergent Biosolution Today - Breaking & Trending Today

The Latest: EU signs Pfizer vaccine contract for 1.8B doses - Vimarsana News

The Latest: EU signs Pfizer vaccine contract for 1.8B doses

Channel3000.com May 20, 2021 9:57 AM By The Associated Press Posted: Updated: Hiro Komae People wearing face masks walk across the famed Shibuya crossing in Tokyo on Thursday, May 20, 2021. Vincent Yu Visitors pass an artwork titled "Martyr, 2019" created by British artist Damien Hirst at Art Basel in Hong Kong Wednesday, May 19, 2021. Art Basel, one of the world's most prestigious modern and contemporary art exhibitions, is returning to Hong Kong in its ninth edition. The prestige art fair is hosting 104 galleries from 23 countries and territories. Mahesh Kumar A A health worker ta...

The Latest: WTO: Develop vaccines in Africa, Latin America - Vimarsana News

The Latest: WTO: Develop vaccines in Africa, Latin America

By The Associated Press BRUSSELS — The head of the World Trade Organization says it’s paramount to diversify vaccine manufacturing and develop production in Africa and Latin America to contain the coronavirus pandemic. On the eve of a global health summit in Rome, WTO Director-General Ngozi Okonjo-Iweala told European Union legislators on Thursday that normal market forces for exports and imports can’t apply when it comes to the life-or-death issue of COVID-19 vaccines. Many of the world’s wealthiest nations were hoarding the shots for their own population. She...

Emergent BioSolutions faces questions from lawmakers in vaccine probe - Vimarsana News

Emergent BioSolutions faces questions from lawmakers in vaccine probe

Emergent BioSolutions faces questions from lawmakers in vaccine probe Emergent BioSolutions executives testify on Capitol Hill Replay Video UP NEXT The beleaguered biotech firm Emergent BioSolutions will face a congressional inquiry Wednesday, scrutinized for what investigators say are the "serious deficiencies" in their manufacturing that led to up to 15 million doses' worth of COVID-19 vaccine ingredients being compromised and disposed of because of cross-contamination. Top Emergent executives Fuad El-Hibri, the company's founder and executive chairman, and Robert Kramer, its chief exec...

Source: msn.com
The Latest: UN: Equitable access to vaccine for Africa - Vimarsana News

The Latest: UN: Equitable access to vaccine for Africa

1 of 40 A woman takes selfie as she receives the Covishield vaccine against COVID-19 in Gauhati, Assam, India, Monday, May 17, 2021. Anupam Nath A heath worker in protective suit takes nasal swab sample of a man to test for COVID-19 in a slum area in Gauhati, Assam state, India, Monday, May 17, 2021. Anupam Nath People stand in queue to receive the Covishield vaccine against COVID-19 in Gauhati, Assam, India, Monday, May 17, 2021. Anupam Nath FILE - In this May 10, 2021, file photo, health workers and volunteers in personal protectiv...

ROSEN, A GLOBAL AND LEADING LAW FIRM, Encourages Emergent BioSolutions Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action – EBS - Vimarsana News

ROSEN, A GLOBAL AND LEADING LAW FIRM, Encourages Emergent BioSolutions Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action – EBS

Home / Top News / ROSEN, A GLOBAL AND LEADING LAW FIRM, Encourages Emergent BioSolutions Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action – EBS ROSEN, A GLOBAL AND LEADING LAW FIRM, Encourages Emergent BioSolutions Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action – EBS NEW YORK, May 14, 2021 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Emergent BioSolutions Inc. (NYSE: EBS) between J...